JPWO2021062307A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021062307A5
JPWO2021062307A5 JP2022519061A JP2022519061A JPWO2021062307A5 JP WO2021062307 A5 JPWO2021062307 A5 JP WO2021062307A5 JP 2022519061 A JP2022519061 A JP 2022519061A JP 2022519061 A JP2022519061 A JP 2022519061A JP WO2021062307 A5 JPWO2021062307 A5 JP WO2021062307A5
Authority
JP
Japan
Prior art keywords
psychosis
schizophrenia
medicament
disorder
symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022519061A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022549335A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/052923 external-priority patent/WO2021062307A1/fr
Publication of JP2022549335A publication Critical patent/JP2022549335A/ja
Publication of JPWO2021062307A5 publication Critical patent/JPWO2021062307A5/ja
Pending legal-status Critical Current

Links

JP2022519061A 2019-09-25 2020-09-25 新規方法 Pending JP2022549335A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962906042P 2019-09-25 2019-09-25
US62/906,042 2019-09-25
PCT/US2020/052923 WO2021062307A1 (fr) 2019-09-25 2020-09-25 Nouvelles méthodes

Publications (2)

Publication Number Publication Date
JP2022549335A JP2022549335A (ja) 2022-11-24
JPWO2021062307A5 true JPWO2021062307A5 (fr) 2023-10-02

Family

ID=75166462

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022519061A Pending JP2022549335A (ja) 2019-09-25 2020-09-25 新規方法

Country Status (4)

Country Link
US (1) US20220362241A1 (fr)
EP (1) EP4034119A4 (fr)
JP (1) JP2022549335A (fr)
WO (1) WO2021062307A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102495941B1 (ko) * 2013-12-03 2023-02-06 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
CN116113622A (zh) * 2020-09-04 2023-05-12 细胞内治疗公司 新的盐、晶体和共晶体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006275702A1 (en) * 2005-07-29 2007-02-08 Concert Pharmaceuticals Inc. Novel pharmaceutical compounds
BR112018015283B1 (pt) * 2016-01-26 2023-09-26 Intra-Cellular Therapies, Inc Compostos orgânicos, composição farmacêutica compreendendo os ditos compostos e uso dos mesmos para o tratamento ou profilaxia de um distúrbio do sistema nervoso central
MX2020000968A (es) * 2017-07-26 2020-09-28 Intra Cellular Therapies Inc Compuestos organicos.
WO2019023063A1 (fr) * 2017-07-26 2019-01-31 Intra-Cellular Therapies, Inc. Composés organiques
MX2020009668A (es) * 2018-03-16 2021-01-08 Intra Cellular Therapies Inc Métodos novedosos.

Similar Documents

Publication Publication Date Title
JP6948426B2 (ja) 補体媒介障害の治療のためのアリール化合物、ヘテロアリール化合物及び複素環式化合物
TWI327472B (en) Transdermal system for varenicline
KR101605151B1 (ko) 화학요법에 의해 유도되는 통증의 예방 또는 치료를 위한 시그마 리간드
ES2732442T3 (es) Compuestos orgánicos
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
CA2749245C (fr) Formulation pour l'administration par voie trans-muqueuse buccale de molecules antalgiques et/ou anti-spasmodiques
JP2021505575A5 (fr)
JP2013510883A5 (fr)
JP7475055B2 (ja) （ｓ）－３－アミノ－４－（ジフルオロメチレニル）シクロペンタ－１－エン－１－カルボン酸の合成法
KR20150047573A (ko) 최면 진정제의 투여 방법
JP2017203046A (ja) ノルイボガインの硫酸エステル
JP2024516421A (ja) Ｍｄｍａ鏡像異性体
JP2007515476A5 (fr)
WO2007137224A2 (fr) Méthode de traitement
CN118201615A (zh) 喹唑啉酮化合物用于治疗癌症的新用途
JP2023133571A (ja) 気分障害のための新規ガンマアミノ酪酸型受容体モジュレーター
JPWO2021062307A5 (fr)
RU2333754C2 (ru) Композиции, содержащие избирательный ингибитор циклооксигеназы-2
JP2013525290A5 (fr)
JP6173352B2 (ja) 筋萎縮性側索硬化症の治療方法
BR112021008153A2 (pt) processo para a produção de formas de administração farmacêuticas contendo inibidores de canais task-1 e task-3 e seu uso para a terapia de distúrbios respiratórios
JP2024517309A (ja) マルチキナーゼ阻害剤の医薬組成物および使用
JP2010509389A (ja) 化学療法剤により誘起された末梢神経毒性の処置に有効なピロロ［１，２−ａ］イミダゾールジオン
JP2023525633A (ja) コロナウイルス感染症の治療のためのスフィンゴシン経路調節化合物
ES2677474T3 (es) Un metabolito de iloperidona para uso en el tratamiento de trastornos psiquiátricos